New research has found that rates of disease caused by the bacterium Streptococcus pneumoniae could be substantially reduced by changing our approach to vaccination. Researchers from the Wellcome Sanger Institute, Simon Fraser ...
Feb 3, 2020
0
176
About 40 percent of the global population is at risk for contracting dengue—the most important mosquito-borne viral infection and a close "cousin" of the Zika virus—and yet, no effective treatment or safe licensed vaccine ...
Mar 28, 2019
0
1
A group of researchers from the School of Agricultural and Veterinary Sciences, at the State University of São Paulo (FCAV-UNESP) in Jaboticabal, are investigating genes that are important for the survival of the bacterial ...
Feb 22, 2019
0
0
Sid Thakur is a professor of population health and pathobiology and the director of NC State's and the College of Veterinary Medicine's Global Health programs. He studies antibiotic resistance in Salmonella and how antibiotic ...
Nov 29, 2018
0
2
The latest in a series of studies led by the Aravinda de Silva Lab at the UNC School of Medicine shows continued promise in a dengue virus vaccine delivered using nanoparticle technology.
Oct 5, 2018
0
67
A 10-year investigation evaluating data from four surveillance systems captured information on the geographic distribution of outbreaks of Salmonella enterica serotype Newport infections in the U.S., who is at greatest risk, ...
Sep 11, 2018
0
0
(HealthDay)—For pediatric and adolescent oncology patients, a single-dose 13-valent pneumococcal conjugate vaccine (PCV13) is safe and immunogenic, according to a study published online July 11 in Cancer.
Jul 19, 2017
0
2
In a new study, researchers inoculated mice with a new DNA vaccine candidate (pVAX1-D1ME) in order to evaluate its efficiency. They found that the vaccine candidate was able to induce persistent humoral and cellular immune ...
Jun 29, 2017
0
16
The use of 4 different 13-valent pneumococcal conjugate vaccine immunization schedules in healthy term infants resulted in no statistically significant differences in antibody levels between the infants after the booster ...
Sep 3, 2013
0
0
A new strategy that cripples the ability of the dengue virus to escape the host immune system has been discovered by A*STAR's Singapore Immunology Network (SIgN). This breakthrough strategy opens a door of hope to what may ...
Aug 13, 2013
0
0
